Why the study?
Does glucose-insulin-potassium (GIK) solution infusion protect myocardial tissue in dogs following experimental coronary artery occlusion?
Does glucose-insulin-potassium (GIK) solution infusion protect myocardial tissue in dogs following experimental coronary artery occlusion?
GIK infusion appears to protect myocardial tissue in the central ischemic area independent of myocardial blood flow in a canine model of coronary occlusion.
Suggests flow-independent myocardial protection by GIK in dogs; leaves open efficacy in human infarction.
To determine the therapeutic effects of glucose-insulin-potassium (GIK) solution, 5 control dogs and 5 GIK-treated dogs were investigated 24 hours after coronary artery occlusion by use of myocardial creatine phosphokinase (CK) activity and myocardial thallium-201 uptake. There was no significant difference in myocardial blood flow estimated by thallium-201 uptake between the control and the GIK group, but myocardial CK activity in the ischemic zone of GIK-treated animals was significantly higher than that of the control group. This suggests that administration of GIK solution is effective in protecting myocardial tissue in the central ischemic area and that this protecting action of GIK seems to be independent of myocardial blood flow.
No takes yet. Share an insight, caveat, or question.
Kambara et al. (1981) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: